Antimicrobial fibres derived from aryl-diazonium conjugation of chitosan with Harakeke (Phormium tenax) and Hemp (Cannabis sativa) Hurd.

Surface functionalisation of natural materials to develop sustainable and environmentally friendly antimicrobial fibres has received great research interest in recent years. Herein, chitosan covalent conjugation via aryl-diazonium based chemistry onto Phormium tenax fibres (PTF) and hemp hurds (HH) was investigated. PTF are fibres derived from Harakeke/New Zealand flax, an indigenous and abundant plant source of leaf fibres, which served as an important 19th century export commodity of New Zealand. HH are obtained as a by-product from the hemp (Cannabis sativa) industry and find applications as traditional construction material, animal bedding, chemical absorbent, insulation, fireboard etc. This study reports aryl-diazonium covalent attachment of chitosan and PD13 (6-O-(3-(2-(N,N-dimethylamino)ethylamino)-2-hydroxypropyl)chitosan), a chitosan derivative with improved antibacterial activity, on to PTF and HH. The modification was confirmed using FTIR, XPS, SEM and water contact angle studies. Comparison of aryl-diazonium versus the use of succinic anhydride bridging for chitosan attachment was also investigated, with the diazonium method giving improved results. The treated PTF and HH fibres had good antibacterial activity against Staphylococcus aureus and this study contributes to the development of sustainable antibacterial fibres using bio-based materials.

Size-Controlled Synthesis of Gold Nanoparticles Tethering Antimicrobial Peptides with Potent Broad-Spectrum Antimicrobial and Antibiofilm Activities.

New antimicrobials are urgently needed to combat the rising global health concern of antibiotic resistance. Antimicrobial peptides (AMPs) are one of the leading candidates as new antimicrobials since they target bacterial membranes and are therefore less prone to bacterial resistance. However, poor enzymatic stability, high production costs, and toxicity are drawbacks that limit their clinical use. Conjugation of AMPs to gold nanoparticles (NPs) may help to improve enzymatic stability and, thus, their overall antimicrobial efficiency. We did a one-pot synthesis of size-controlled (10 nm) gold NPs selectively conjugated to lipopeptides and determined their antibacterial activity. The conjugates exhibited potent (0.13-1.25 µM) antimicrobial activity against clinical isolates, including Gram-positive methicillin-resistant Staphylococcus aureus (S. aureus) ATCC33593, Gram-negative Escherichia coli (E. coli) CTX-M-14, multidrug-resistant Pseudomonas aeruginosa LESB58 and Acinetobacter baumannii ATCC19606, and showed promising activity (90% inhibition of initial biofilms and 80% reduction of preformed biofilms) against S. aureus and E. coli DH5α biofilms at low micromolar concentrations. The conjugates were stable in rat serum and not toxic to representative mammalian cell lines in vitro (≤64 µM) and in vivo (≤100 µM).

Synthesis and antibacterial analysis of C-6 amino-functionalised chitosan derivatives.

Synthesis of 6-O-(3-alkylamino-2-hydroxypropyl) derivatives of chitosan was achieved using a four-step strategy of N-protection, O-epoxide addition, epoxide ring opening using an amine and N-deprotection. Benzaldehyde and phthalic anhydride were used for the N-protection step, producing N-benzylidene and N-phthaloyl protected derivatives, respectively, resulting in two corresponding final 6-O-(3-alkylamino-2-hydroxypropyl) derivative series, BD1-BD6 and PD1-PD14. All the compounds were characterized using FTIR, XPS and PXRD studies and tested for antibacterial efficacy. The phthalimide protection strategy was found to be easier to apply and effective in terms of the synthetic process and improvement in antibacterial activity. Amongst the newly synthesized compounds, PD13 (6-O-(3-(2-(N,N-dimethylamino)ethylamino)-2-hydroxypropyl)chitosan) was the most active with eight times greater activity compared to the unmodified chitosan and, PD7 6-O-(3-(3-(N-(3-aminopropyl)propane-1,3-diamino)propylamino)-2-hydroxypropyl)chitosan) having a four-fold activity than chitosan, was found to be the second most potent derivative. This work has produced new chitosan derivatives those are more potent than chitosan itself and show promise in antimicrobial applications.

Recent Developments in Antimicrobial-Peptide-Conjugated Gold Nanoparticles.

The escalation of multidrug-resistant pathogens has created a dire need to develop novel ways of addressing this global therapeutic challenge. Because of their antimicrobial activities, the combination of antimicrobial peptides (AMPs) and nanoparticles is a promising tool with which to kill drug-resistant pathogens. In recent years, several studies using AMP-nanoparticle conjugates, especially metallic nanoparticles, as potential antimicrobial agents against drug-resistant pathogens have been published. Among these, antimicrobial-peptide-conjugated gold nanoparticles (AMP-AuNPs) are particularly attractive because of the nontoxic nature of gold and the possibility of fine-tuning the AMP-NP conjugation chemistry. The following review discusses recent developments in the synthesis and antimicrobial activity studies of AMP-AuNPs. The classification of AMPs, their mechanisms of action, methods used for functionalizing AuNPs with AMPs, and the antimicrobial activities of the conjugates are discussed.